Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
This study evaluates the safety and effectiveness of Cariprazine for people with schizophrenia.
This study ended early.
Multiple locations, including AkitaResearchers studied KarXT, tracking side effects to assess safety in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Los AlamitosThis study evaluated the safety of CY6463 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Long BeachA Phase 1, Multicenter, Open-label, Dose-Escalation Trial to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Randomized, Double Blind, Placebo Controlled, Study to Demonstrate the Cognitive Enhancing Effects of BF2.649 in People With Schizophrenia and Schizoaffective Disorder
This study has finished and is no longer accepting participants.
In DallasResearchers compared Roluperidone 64 mg, Roluperidone 32 mg and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including RogersThis study evaluates the safety and effectiveness of NaBen® for people with schizophrenia.
This study ended early.
In PasadenaResearchers compared Risperidone ISM 75 mg, Risperidone ISM 100 mg and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including RogersResearchers compared Risperidone ISM 75 mg and Risperidone ISM 100 mg to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including RogersA Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Subjects With Cognitive Impairment Associated With Schizophrenia, Followed by Open-Label Treatment
This study ended early.
Multiple locations, including PhoenixThis study evaluates the safety and effectiveness of Valbenazine for people with schizophrenia.
This study ended early.
Multiple locations, including San JoseA Phase 3 Study to Assess the Long Term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 in Subjects With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.